BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30611103)

  • 1. Current pharmaceutical developments in atopic dermatitis.
    Misery L; Huet F; Gouin O; Ständer S; Deleuran M
    Curr Opin Pharmacol; 2019 Jun; 46():7-13. PubMed ID: 30611103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
    Soeberdt M; Kilic A; Abels C
    Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs on the Horizon for Chronic Pruritus.
    McEwen MW; Fite EM; Yosipovitch G; Patel T
    Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
    Huang IH; Chung WH; Wu PC; Chen CB
    Front Immunol; 2022; 13():1068260. PubMed ID: 36569854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK/STAT inhibitors for the treatment of atopic dermatitis.
    Rodrigues MA; Torres T
    J Dermatolog Treat; 2020 Feb; 31(1):33-40. PubMed ID: 30703333
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines.
    Renert-Yuval Y; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):28-35. PubMed ID: 31622669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses.
    Garcia-Melendo C; Cubiró X; Puig L
    Actas Dermosifiliogr (Engl Ed); 2021; 112(7):586-600. PubMed ID: 34030992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
    Nakashima C; Yanagihara S; Otsuka A
    Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease.
    Howell MD; Fitzsimons C; Smith PA
    Ann Allergy Asthma Immunol; 2018 Apr; 120(4):367-375. PubMed ID: 29454096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging treatments for atopic dermatitis.
    Katoh N
    J Dermatol; 2021 Feb; 48(2):152-157. PubMed ID: 32677122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
    Munera-Campos M; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
    Chu CY
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives.
    Munera-Campos M; Carrascosa JM
    Actas Dermosifiliogr; 2023 Sep; 114(8):680-707. PubMed ID: 37105270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapies and the potential for a personalized approach to atopic dermatitis.
    Balakirski G; Novak N
    Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):368-377. PubMed ID: 34074875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrocitinib for the treatment of atopic dermatitis.
    Crowley EL; Nezamololama N; Papp K; Gooderham MJ
    Expert Rev Clin Immunol; 2020 Oct; 16(10):955-962. PubMed ID: 32969750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK-inhibitors in dermatology: current evidence and future applications.
    Ciechanowicz P; Rakowska A; Sikora M; Rudnicka L
    J Dermatolog Treat; 2019 Nov; 30(7):648-658. PubMed ID: 30433838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases.
    Kahn J; Deverapalli SC; Rosmarin D
    Semin Cutan Med Surg; 2018 Sep; 37(3):198-208. PubMed ID: 30215638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in systemic treatment of atopic dermatitis].
    Werfel T; Wollenberg A; Pumnea T; Heratizadeh A
    Hautarzt; 2018 Mar; 69(3):217-224. PubMed ID: 29470609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies.
    Kogame T; Egawa G; Kabashima K
    Immunol Med; 2023 Sep; 46(3):112-120. PubMed ID: 37254967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapies for atopic dermatitis: JAK inhibitors.
    Cotter DG; Schairer D; Eichenfield L
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S53-S62. PubMed ID: 29248518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.